Studies of the Mechanism by which Androgens Enhance Mitogenesis and Differentiation in Bone Cells

Journal of Clinical Endocrinology and Metabolism

Volumn 71, Issue 5, 1990, Pages 1322-1329

  Kasperk, Christian ^a   Fitzsimmons, Robert ^a   Strong, Donna ^a   Mohan, Subburaman ^a   Jennings, John ^a   Wergedal, Jon ^a   Baylink, David ^a  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; FIBROBLAST GROWTH FACTOR; RADIOISOTOPE; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANDROGENS; ANIMAL; BONE AND BONES; CELL DIFFERENTIATION; CELLS, CULTURED; CHICKENS; COMPARATIVE STUDY; CULTURE MEDIA; DNA; HUMAN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MICE; MITOSIS; MODELS, BIOLOGICAL; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MURINAE;

EID: 0025006203     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-71-5-1322     Document Type: Article

References (41)

1. Rubinstein HS, Salomon ML. The growth depressing effect of large doses of testosterone propionate in the castrate albino rat. Endocrinology. 1941;28:112-4.
2. Clein LJ, Kowalewski K. Some effects of cortisone and an anabolic steroid on healing of experimental fractures. Can J Surg. 1962;5:108-17.
3. Wiancko KB, Kowalewski K. Strength of callus in fractured humerus of rat treated with anti-anabolic and anabolic compounds. Acta Endocrinol (Copenh). 1961;36:310-8.
4. Ronning O, Makinen E, Lahtinen K, Faijola E. Effect of nandro-lone phenylpropionate on the bone of young rats. Endocrinology. 1964;75:477-84.
5. Chestnut CH, Ivey JL, Gruber HE, et al. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanism of action. Metabolism. 1983;32:571-80.
6. Buchanan JR, Hospodar P, Myers C, Leuenberger P, Demers LM. Effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab. 1988;67:937-43.
7. Foresta C, Ruzza G, Mioni R, et al. Osteoporosis and decline of gonadal function in the elderly male. Horm Res. 1984;19:18-22.
8. Colvard DS, Eriksen EF, Keeting PE, et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA. 1989;86:854-7.
9. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT, Baylink DJ. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology. 1989;124:1576-8.
10. Ishii DM, Shooter EM. Regulation of nerve growth factor in mouse submaxillary glands by testosterone. J Neurochem. 1975;25:843-7.
11. Gresik EW, Barka T. Epidermal growth factor, renin and protease in hormonally responsive duct cells of the mouse sublingual gland. Anat Rec. 1983;205:169-76.
12. Benz D, Kasperle C, Bard D, et al. Human osteoblastic osteosarcoma cells exhibit androgen receptors and androgenic responses. Proc of the 10th Int Conf of Calcium Regulating Hormones (ICCRH). 1989;S261.
13. Mohan S, Jennings JC, Linkhart TA, Baylink DJ. Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-2. Biochim Biophys Acta. 1988;966:44-55.
14. Linkhart TA, Jennings JC, Mohan S, Wakley GK, Baylink DJ, Characterization of mitogenic activities from bovine bone matrix. Bone. 1986;7:479-87.
15. Jennings JC, Mohan S, Linkhart TA, Widstrom R, Baylink DJ. Comparison of the biological actions of TGFβi and TGFβ2: differential activity in endothelial cells. J Cell Physiol. 1988;137:167-72.
16. Rodbard D. Data processing for radioimmunoassays: an overview. In: Natelson S, Pesce AJ, Dietz AA, eds. Clinical chemistry and immunochemistry. Clinical and cellular basis and applications in disease. Washington DC: American Association of Clinical Chemists; 1978;477-94.
17. Goodman HM, Levy LK. Preparation and biological activity of polyiodinated human growth hormone. Endocrinology. 1983;113:2017-23.
18. Krett NL, Heaton JH, Gelehrter TD. Modulation of insulin-like growth factor actions in H-35 rat hepatoma cells. Endocrinology. 1987;120:483-90.
19. Mohan S, Bautista CM, Herring SJ, Linkhart TA, Baylink DJ. Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium. Endocrinology. 1990;126:2534-42.
20. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-9.
21. Lehrbach H, Diamond D, Wozney JM, Boedtker H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry. 1977;16:4743-51.
22. Schleicher and Schuell. Transfer and immobilization of nucleic acids to 545 solid supports. Schleicher and Schuell Technical Bulletin 700, Keene, NH. 1987.
23. Herrin DL, Schmidt GW. Rapid, reversible staining of Northern blots prior to hybridization. Biotechniques. 1988;6:196-200.
24. Derynck R, Jarett JA, Chen EY, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 1985;316:701-5.
25. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983;132:6-13.
26. Kasperk CH, Wergedal JE, Mohan S, Long DL, Lau W, Baylink DJ. Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors. In Press.
27. Farley J, Hall S, Herring S, Tarbaux N. Differentiation dependent differences in the proliferative responses of human osteosarcoma cell subpopulations to IGFl, IGF2 and NaF [Abstract]. J Bone Mineral Res. 1989;4:S130.
28. Webb NR, Madisen L, Rose TM, Purchio AF. Structural and sequence analysis of TGF-β2 cDNA clones predicts two different precursor proteins produced by alternative mRNA splicing. DNA. 1988;7:493-7.
29. Albright F. The effect of hormones on osteogenesis in man. Recent Prog Horm Res. 1947;1:293-353.
30. Albright F, Reifenstein C. The parathyroid glands and metabolic bone disease. Baltimore: Williams and Wilkens, 1948.
31. Baran DT, Bergfeld MA, Teitelbaum SL, Avioli LV. Effect of testosterone on bone formation in an osteoporotic hypogonadal male. Calcif Tissue Res. 1978;26:103-6.
32. Wild RA, Buchanan JR, Myers C, Demers LM. Declining adrenal androgens: an association with bone loss in aging women. Proc Soc Exp Biol Med. 1987;186:355-60.
33. Finkeistein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF. Osteoporosis in men with idiopathic hypogonadism. Ann Intern Med. 1987;106:354-61.
34. Stepan JJ, Kasperk CH, Lachman M, Zverina J, Pacovsky V, Baylink DJ. Castration in young male adults causes bone loss. Effect of calcitonin treatment [Abstract]. J Bone Mineral Res. 1989; 4(Suppl 1):S232.
35. Noda M, Rodan GA. Type beta transforming growth factor (TGFβ) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells. J Cell Physiol. 1987;133:426-37.
36. Dawid IB, Sargent TD. Xenopus laevis in developmental and molecular biology. Science. 1988;240:1443-8.
37. Bejcek BE, Li DY, Deuel TF. Transformation by v-sis occurs by an internal autoactivation mechanism. Science. 1989;245:1496-9.
38. Dunbar CE, Browder TM, Abrams JS, Nienhuis AW, COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth. Science. 1989;245:1493-6.
39. Mohan S, Linkhart TA, Rosenfeld R. Characterization of the receptor for insulin-like growth factor 2 in bone cells. J Cell Physiol. 1989;140:169-76.
40. Pfeilschifter J, D’Souza SM, Mundy GR. Effects of transforming growth factor-β on osteoblastic osteosarcoma cells. Endocrinology. 1987;121:212-8.
41. Rosa F, Roberts AB, Danielpour D, Dart LL, Sporn MB, Dawid IB. Mesoderm induction in amphibians: the role of TGFβ2-like factors. Science. 1988;239:783-5.